Brandon White, Axiom CEO
April 28, 2025 07:00 AM EDTUpdated 08:32 AM
Financing
AI

Ex­clu­sive: Can AI re­place an­i­mal test­ing? A new biotech launch­es to find out

Andrew Dunn

Senior Biopharma Correspondent

Bran­don White start­ed his ca­reer like a Sil­i­con Val­ley stereo­type — as a 20-year-old who skipped col­lege to join Uber’s ma­chine learn­ing team in 2014. …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Boehringer’s up­dat­ed re­sults in HER2-mu­tat­ed lung can­cer im­press

Schol­ar Rock names new CEO, adds biotech vet­er­ans in C-suite re­build

Mer­ck KGaA to buy rare can­cer biotech Spring­Works for $3.9B

Rev­o­lu­tion Med­i­ci­nes' KRAS drug shows po­ten­tial in ear­ly cut of lung can­cer da­ta

Bio­haven gets an up to $600M in­vest­ment; Prile­nia, Fer­rer make a deal in Eu­rope

sponsored

Rev­o­lu­tion­iz­ing obe­si­ty treat­ment: Could mi­to­chon­dria hold the key to un­lock­ing fat-spe­cif­ic weight loss?

A service from the Financial Times